We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
GivePenny is a digital toolkit for creating charity fundraising events. The company allows charities to create and promote fundraising campaigns via subscription and 'per donation' fees. GivePenny's proprietary platform allows supporters to join one of these campaigns and personalise their fundraising pages via apps like Spotify, Strava, Twitch, YouTube, and Fitbit. GivePenny asserts that the content and data from the aforementioned apps, coupled with its pledge-based payment options, drives donations. GivePenny has hosted 72 virtual events since March 2020 and processed over £700,000 in donations. Its customers include the world's largest research charity, Cancer Research UK. The company is hosted on Microsoft Azure. It has also featured in publications like The Guardian, Sky News, and BBC. The company will use the investment to scale its business and recruit personnel across sales, marketing, and software development portfolios.

Pitch Rated

54%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £118,228
Padoq is a creative game-changing mobile application development platform for organizations and businesses which enables customers of all forms and dimensions to engage, organise and monetise. Its functionality includes Photo, file and video sharing, Event Management, Payment collection etc. The company is listed on the G-Cloud public sector procurement framework, is ISO-certified and, it has won Venturefest in the NW and membership of the Maserati 100 by the Sunday Times. With the proceeds, the company will target the release of a self-serve advertising platform that will allow communities and businesses in benefiting controlled advert inclusion.

Pitch Rated

54%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £850,117
Whatbook is a book discovery and social network app for readers. Its goal is to become the go-to platform for everything book related and ultimately to get people reading more. The company's app is live on iOS and Android with 8,000+ users growing daily. It saved up to £3,000 by shooting its campaign video at home due to COVID-19 and put that into developing new features for its app. Whatbook aims to become a segment leader in the projected $100 billion book industry and work with publishers and booksellers on the most effective route to success and getting more people reading. The company will use the investment for marketing and platform development.

Pitch Rated

54%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £255,374
Ayoa by OpenGenius is an intelligent digital workspace for remote teams to manage meetings, build plans and action tasks. Launched in June 2019, Ayoa already has over 12,000 paying users and c. 300,000 users who have signed up for the free product. Ayoa is used by many people at reputable organisations such as the BBC, Ernst & Young, and Cambridge University. It has an average customer rating of 4.5 stars from 1,000+ reviews across the Apple App Store, Google Play and Capterra. Moreover, the company's CEO, Chris Griffiths, has been featured in several publications such as the BBC, The Times, Forbes, GQ, and The Telegraph as an expert on topics such as creativity and productivity. With the funds received, the company will further develop its product by releasing newer features such as Smart Meetings, and Intelligent Digital Workspace, smoothening powerful integrations and integrating AI tools into the application.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,143,029
C-Major is a medical technology company. It asserts that over 2 million people suffer a Needle Stick Injury (NSI) every year and are at risk of contracting blood-borne viruses such as Hepatitis and HIV. It aspires to resolve this crisis by bringing to market its patented medical device, Controlled Helical Retraction Device, to prevent NSIs. The company argues that the device contains a ‘Helical Track’ mechanism for controlled acceleration of the needle during retraction as well as a ‘Sealed Port’ to minimise any blood splatter. C-Major endeavours to disrupt the $5.5 billion safety syringe market with its product. It is backed by the UK 'Innovation Seed' fund. C-Major will use the investment to complete the final design of its product for manufacture and assembly ahead of a Series A funding round in 2021.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £211,595
GeoDB is a decentralised peer-to-peer big data-sharing ecosystem, powered by Blockchain Technology, which rewards you for data generated. Users upload their data to the ecosystem and in exchange get rewarded for the data generated and datasets are purchased by buyers to access the data pool. It aims to solve the existing inefficiencies of the data industry. Till now, the company has launched Data Generator Network and Data Generator App GeoCash. The company has secured partnerships with five big data companies from Europe & Latin America. Their app is available on the google play store. Also, they have over 15,000 social media followers, including Telegram, Wechat, Twitter, Linkedin, and Medium. The proceeds will be spent on team building, marketing and growth of their Token to increase its visibility and presence in more significant and liquid exchanges.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,527,399
Swipii connects users to local brick-and-mortar businesses in their vicinity via its app. It allows users to earn cashback on every transaction done through the app via a debit/credit card and allows local businesses to reach more customers and run their business profitably. Swipii has 26,500 registered users on its platform and has witnessed £440,000 spent at 212 businesses nationwide. The company argues that despite the COVID lockdown, 33% of Swipii users made >1 cashback transaction each month in 2020. It aims to become a contender in the £60 billion global cashback market. Swipii has featured in The Guardian, BBC, and Wired. It won the 2016 UK Digital Experience Awards and its founders were mentioned in Forbes '30 under 30' winners. The company will use the investment to scale up user and business acquisition in new cities across the UK before going global.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £921,643
TiPJAR is a global cashless tipping platform that allows users to tip hospitality staff, buskers and hairdressers using 'Open Banking'. The company points out that tipped workers are earning less each year as cash transactions reduce, with Covid-19 having furthered this problem. It claims to have a powerful distribution engine empowering staff to control and share tips fairly and transparently. TiPJAR argues that its portal has been approved by Her Majesty's Revenue and Customs (HMRC) as an alternative to the traditional tronc system. The company asserts that its app is already live in over 1650 venues, with over 100,000 users using the platform. The company aspires to dominate the estimated global tipping market worth a combined $100 billion per year. TiPJAR stresses that it is also the world’s first multi-currency, scalable solution that works in multiple countries. They state they will use the investment received to prepare the business for rapid scale-up growth.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,346,659
Anastasis Biotec (AB) is a company that is developing a human protein-based product, Syntana-4 (S-4), that inhibits Cancer Stem Cells (CSC) - the growth engine of cancer. The global cancer drug market was at ~$200 billion in 2019. S-4 will initially target use for patients with relapsed prostate cancer which caused 3.8% of global cancer deaths in 2018. The company asserts that S-4 will have low manufacturing costs, making it affordable, enabling ‘mass-market’ sales. AB has raised £450,000 in equity convertible loans and grants in 2019 & 2020, including an Innovate-UK award. It is also aiming to progress S-4 further in collaboration with the University of Chicago’s cancer stem cell therapeutics Research and development (R&D) program. The company will use the investment to complete lab-testing before starting clinical trials.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £270,543
CrowdToLive is a Financial Conduct Authority (FCA) regulated financial technology company that seeks to revolutionise residential property financing and investment. It claims that 4 out of 10 young homeowners in the UK have had their mortgage applications rejected. CrowdToLive intends to change this by facilitating a circular flow of finance between buy to let investors and the homebuyers. It argues that its platform allows buyers to own their homes without incurring debt and lets investors reap the rewards of the housing market without the hassle of tenant management. The company claims it has built a community of over 7,000 users, submitted over 2,600 properties for a value of circa GBP 600 million, and is a part of accelerator programmes such as Virgin Start-Up Accelerator Programme and Barclays Eagle Lab Accelerator Programme. CrowdToLive intends to use 10% of the investment to support international expansion, 15% towards business development, 40% towards hiring key personnel, 25% towards upgrading its IT infrastructure, and 10% towards marketing.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £339,744
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph